http://jco.ascopubs.org/content/ear...id=1&usestrictdates=yes&resourcetype=HWCIT&ct
Conclusion There was no apparent difference between the treatment arms. These results challenge the use of doxorubicin-eluting beads for chemoembolization of HCC.
For those interested in BTG DC beads. This data was first part published in 2013, but only this last week accepted for publication in jco.asco.
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluti
Add to My Watchlist
What is My Watchlist?